Genomic screening for monogenic forms of diabetes

Area of Science:

• Genetics
• Endocrinology
• Molecular Biology

Background:

• Type II diabetes mellitus (T2DM) exhibits complex genetics, involving common variants and rare single-gene mutations.
• Maturity-onset diabetes of the young (MODY) represents an uncommon (2-3%) Mendelian form of T2DM, posing diagnostic challenges.
• Distinguishing MODY from common T2DM is vital for appropriate patient management and genetic counseling.

Discussion:

• A gene panel testing approach was utilized to screen diabetic patients for single-gene causes of MODY.
• The study identified pathogenic variants in seven genes responsible for MODY in a subset of patients.
• These findings underscore the potential for Mendelian MODY to be misdiagnosed as typical T2DM.

Key Insights:

• Nearly 2% of younger patients with diabetes harbored pathogenic variants in genes associated with MODY.
• Gene panel testing proves effective in identifying single-gene causes of diabetes.
• The study highlights the clinical significance of recognizing MODY in diabetic populations.

Outlook:

• Results support the broader implementation of genetic testing for diabetes diagnosis.
• Clinical genome sequencing holds promise for uncovering genetic underpinnings of diabetes.
• Enhanced genetic diagnostics can refine T2DM classification and treatment strategies.